Ellagic acid inhibits human pancreatic cancer growth in Balb c nude mice.

Ellagic acid (EA) is a polyphenol found in several plants and fruits. The objectives of this study were to examine the molecular mechanisms by which EA inhibits pancreatic cancer growth in Balb C nude mice. PANC-1 cells were injected subcutaneously into Balb c nude mice, and tumor-bearing mice were treated with EA. The expression of Akt, Shh and Notch and their target gene products were measured by the immunohistochemistry and Western blot analysis. Treatment of PANC-1 xenografted mice with EA resulted in significant inhibition in tumor growth which was associated with suppression of cell proliferation and caspase-3 activation, and induction of PARP cleavage. EA inhibited the expression of Bcl-2, cyclin D1, CDK2, and CDK6, and induced the expression of Bax in tumor tissues compared to untreated control group. EA inhibited the markers of angiogenesis (COX-2, HIF1α, VEGF, VEGFR, IL-6 and IL-8), and metastasis (MMP-2 and MMP-9) in tumor tissues. Furthermore, treatment of mice with EA caused a significant inhibition in phospho-Akt, Gli1, Gli2, Notch1, Notch3, and Hey1. EA also reversed epithelial to mesenchymal transition by up-regulating E-cadherin and inhibiting the expression of Snail, MMP-2 and MMP-9. These data suggest that EA can inhibit pancreatic cancer growth, angiogenesis and metastasis by suppressing Akt, Shh and Notch pathways. In view of the fact that EA could effectively inhibit human pancreatic cancer growth by suppressing Akt, Shh and Notch pathways, our findings suggest that the use of EA would be beneficial for the management of pancreatic cancer.

[1]  G. Semenza.  HIF-1 inhibitors for cancer therapy: from gene expression to drug discovery. , 2009, Current pharmaceutical design.

[2]  Zhiwei Wang,et al.  Pancreatic cancer stem cells and EMT in drug resistance and metastasis. , 2009, Minerva chirurgica.

[3]  John B. Shoven,et al.  I , Edinburgh Medical and Surgical Journal.

[4]  S. Roy,et al.  GANT-61 inhibits pancreatic cancer stem cell growth in vitro and in NOD/SCID/IL2R gamma null mice xenograft. , 2013, Cancer letters.

[5]  R. Hruban,et al.  A new mouse model of pancreatic cancer: PTEN gets its Akt together. , 2005, Cancer cell.

[6]  J. Neoptolemos,et al.  Surgical and medical therapy for pancreatic carcinoma. , 2002, Best practice & research. Clinical gastroenterology.

[7]  P Vaupel,et al.  Biological consequences of tumor hypoxia. , 2001, Seminars in oncology.

[8]  Yinmo Yang,et al.  Hedgehog signaling pathway regulates human pancreatic cancer cell proliferation and metastasis. , 2013, Oncology reports.

[9]  S. Shankar,et al.  Effects of sequential treatments with chemotherapeutic drugs followed by TRAIL on prostate cancer in vitro and in vivo , 2005, The Prostate.

[10]  S. Shankar,et al.  Hedgehog Signaling Antagonist GDC-0449 (Vismodegib) Inhibits Pancreatic Cancer Stem Cell Characteristics: Molecular Mechanisms , 2011, PloS one.

[11]  Jun Yao,et al.  Inhibition of Notch3 enhances sensitivity to gemcitabine in pancreatic cancer through an inactivation of PI3K/Akt-dependent pathway , 2010, Medical oncology.

[12]  K. Shetty,et al.  Enhancing health benefits of berries through phenolic antioxidant enrichment: focus on cranberry. , 2005, Asia Pacific journal of clinical nutrition.

[13]  F. Sarkar,et al.  The Tyrosine Kinase c-Src Directly Mediates Growth Factor-Induced Notch-1 and Furin Interaction and Notch-1 Activation in Pancreatic Cancer Cells , 2012, PloS one.

[14]  F. Kruyt,et al.  Targeting apoptosis pathways in lung cancer. , 2013, Cancer letters.

[15]  C. Wright,et al.  Ongoing Notch signaling maintains phenotypic fidelity in the adult exocrine pancreas. , 2012, Developmental biology.

[16]  A. Durczyński,et al.  Prostaglandin E2 (PGE2) in Portal Blood in Patients with Pancreatic Tumor—A Single Institution Series , 2012, Journal of investigative surgery : the official journal of the Academy of Surgical Research.

[17]  N. Lehwald,et al.  Notch 1 tumor expression is lacking in highly proliferative pancreatic neuroendocrine tumors , 2013, Endocrine.

[18]  Paula D. Bos,et al.  Metastasis: from dissemination to organ-specific colonization , 2009, Nature Reviews Cancer.

[19]  M. Mutanen,et al.  Chemoprevention by white currant is mediated by the reduction of nuclear β-catenin and NF-κB levels in Min mice adenomas , 2008, European journal of nutrition.

[20]  F. Radtke,et al.  Notch and cancer: a double-edged sword , 2007, Cellular and Molecular Life Sciences.

[21]  A. Arlt,et al.  Targeting apoptosis pathways in pancreatic cancer. , 2013, Cancer letters.

[22]  Gerald C. Chu,et al.  GLI1 is regulated through Smoothened-independent mechanisms in neoplastic pancreatic ducts and mediates PDAC cell survival and transformation. , 2009, Genes & development.

[23]  M. Singer,et al.  Effect of Non-Alcoholic Compounds of Alcoholic Drinks on the Pancreas , 2007, Pancreatology.

[24]  S. Shankar,et al.  Sulforaphane synergizes with quercetin to inhibit self-renewal capacity of pancreatic cancer stem cells. , 2011, Frontiers in bioscience.

[25]  Y. Seong,et al.  ZSTK474, a PI3K inhibitor, suppresses proliferation and sensitizes human pancreatic adenocarcinoma cells to gemcitabine. , 2011, Oncology reports.

[26]  J. Jensen,et al.  Notch mediated patterning and cell fate allocation of pancreatic progenitor cells , 2011 .

[27]  G. Semenza,et al.  Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1 , 1996, Molecular and cellular biology.

[28]  M. Singer,et al.  Beer and its Non-Alcoholic Compounds: Role in Pancreatic Exocrine Secretion, Alcoholic Pancreatitis and Pancreatic Carcinoma , 2010, International journal of environmental research and public health.

[29]  Sarah E. Seton-Rogers.  Tumour suppressors: Different roads to inactivation , 2009, Nature Reviews Cancer.

[30]  Marianne D. Castillo,et al.  IL-8 signaling plays a critical role in the epithelial-mesenchymal transition of human carcinoma cells. , 2011, Cancer research.

[31]  E. Neilson,et al.  Biomarkers for epithelial-mesenchymal transitions. , 2009, The Journal of clinical investigation.

[32]  Gregory Y. Lauwers,et al.  Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis , 2003, Nature.

[33]  P. Steeg.  Tumor metastasis: mechanistic insights and clinical challenges , 2006, Nature Medicine.

[34]  E. Gold,et al.  Epidemiology of and risk factors for pancreatic cancer. , 1998, Surgical oncology clinics of North America.

[35]  V. Go,et al.  Ellagic acid induces apoptosis through inhibition of nuclear factor kappa B in pancreatic cancer cells. , 2008, World journal of gastroenterology.

[36]  Bechien U. Wu,et al.  Genetic Markers of Malignant Transformation in Intraductal Papillary Mucinous Neoplasm of the Pancreas: A Meta-Analysis , 2012, Pancreas.

[37]  L. Tran,et al.  Cell Intrinsic Role of COX-2 in Pancreatic Cancer Development , 2012, Molecular Cancer Therapeutics.

[38]  Benjamin Purow,et al.  Notch inhibition as a promising new approach to cancer therapy. , 2012, Advances in experimental medicine and biology.

[39]  Grippo Pj,et al.  Signaling pathways mediating epithelial- mesenchymal crosstalk in pancreatic cancer: Hedgehog, Notch and TGFβ -- Pancreatic Cancer and Tumor Microenvironment , 2012 .

[40]  Jessica Lo,et al.  HIF‐1α is required for solid tumor formation and embryonic vascularization , 1998 .

[41]  H. Ryan,et al.  HIF-1 alpha is required for solid tumor formation and embryonic vascularization. , 1998, The EMBO journal.

[42]  Matthew G. Vander Heiden,et al.  Bcl-2 proteins: regulators of apoptosis or of mitochondrial homeostasis? , 1999, Nature Cell Biology.

[43]  J. Folkman.  Role of angiogenesis in tumor growth and metastasis. , 2002, Seminars in oncology.

[44]  G. Fong.  Mechanisms of adaptive angiogenesis to tissue hypoxia , 2008, Angiogenesis.

[45]  L. C. Murtaugh,et al.  Notch and Kras in pancreatic cancer: At the crossroads of mutation, differentiation and signaling , 2009, Cell cycle.

[46]  S. Shankar,et al.  Sonic Hedgehog Signaling Inhibition Provides Opportunities for Targeted Therapy by Sulforaphane in Regulating Pancreatic Cancer Stem Cell Self-Renewal , 2012, PloS one.

[47]  M. Scott,et al.  Patching the gaps in Hedgehog signalling , 2007, Nature Cell Biology.

[48]  Donghui Li,et al.  Molecular epidemiology of pancreatic cancer , 2001, International journal of gastrointestinal cancer.

[49]  G. Semenza,et al.  Regulation of angiogenesis by hypoxia-inducible factor 1. , 2006, Critical reviews in oncology/hematology.

[50]  Donald J L Jones,et al.  Notch3 and Hey-1 as Prognostic Biomarkers in Pancreatic Adenocarcinoma , 2012, PloS one.

[51]  N. McCarthy.  Metastasis: Route master , 2009, Nature Reviews Cancer.

[52]  J. Testa,et al.  Frequent activation of AKT2 kinase in human pancreatic carcinomas , 2002, Journal of cellular biochemistry.

[53]  M. Ullah,et al.  Celecoxib and GABA Cooperatively Prevent the Progression of Pancreatic Cancer In Vitro and in Xenograft Models of Stress-Free and Stress-Exposed Mice , 2012, PloS one.

[54]  Lawrence Lum,et al.  The Hedgehog Response Network: Sensors, Switches, and Routers , 2004, Science.

[55]  P. Ratcliffe,et al.  Regulation of angiogenesis by hypoxia: role of the HIF system , 2003, Nature Medicine.

[56]  A. Abioye,et al.  Pancreatic carcinoma. , 2020, Journal of the National Medical Association.

[57]  S. Shankar,et al.  Inhibition of sonic hedgehog pathway and pluripotency maintaining factors regulate human pancreatic cancer stem cell characteristics , 2012, International journal of cancer.

[58]  J. Merchant,et al.  Hedgehog signaling and gastrointestinal cancer. , 2010, Biochimica et biophysica acta.

[59]  T. Brabletz.  To differentiate or not — routes towards metastasis , 2012, Nature Reviews Cancer.

[60]  A. Giaccia,et al.  Hypoxic gene expression and metastasis , 2004, Cancer and Metastasis Reviews.

[61]  N. McCarthy.  Metastasis: Influencing bad behaviour , 2009, Nature Reviews Cancer.

[62]  A. Maitra,et al.  Notch signaling pathway targeted therapy suppresses tumor progression and metastatic spread in pancreatic cancer. , 2013, Cancer letters.

[63]  Duane H. Hamilton,et al.  Influence of IL-8 on the epithelial-mesenchymal transition and the tumor microenvironment. , 2012, Future oncology.

[64]  S. Grant,et al.  Apoptosis regulators. , 2003, Reviews in clinical and experimental hematology.

[65]  C. Thompson,et al.  The role of the Bcl-2 family in the regulation of outer mitochondrial membrane permeability , 2000, Cell Death and Differentiation.

[66]  R. Kuttan,et al.  Inhibition of liver fibrosis by ellagic acid. , 1996, Indian journal of physiology and pharmacology.

[67]  S. Hingorani,et al.  EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer. , 2008, Frontiers in bioscience : a journal and virtual library.

[68]  J. Folkman.  Angiogenesis and proteins of the hemostatic system , 2003, Journal of thrombosis and haemostasis : JTH.

[69]  S. Shankar,et al.  Sulforaphane regulates self-renewal of pancreatic cancer stem cells through the modulation of Sonic hedgehog–GLI pathway , 2012, Molecular and Cellular Biochemistry.

[70]  A. Iafrate,et al.  Novel Xenograft and Cell Line Derived From an Invasive Intraductal Papillary Mucinous Neoplasm of the Pancreas Give New Insights Into Molecular Mechanisms , 2010, Pancreas.

[71]  Suzanne Cory,et al.  The Bcl-2 family: roles in cell survival and oncogenesis , 2003, Oncogene.

[72]  S. Leach,et al.  Signaling pathways mediating epithelial- mesenchymal crosstalk in pancreatic cancer: Hedgehog, Notch and TGFβ , 2012 .

[73]  M. Lauth,et al.  Hedgehog signaling and pancreatic tumor development. , 2011, Advances in cancer research.

[74]  M. Nieto,et al.  Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. , 2009, The Journal of clinical investigation.

[75]  P. Adams,et al.  Ras, PI3K/Akt and senescence , 2011, Small GTPases.

[76]  S. Dry,et al.  PTEN loss accelerates KrasG12D-induced pancreatic cancer development. , 2010, Cancer research.

[77]  Bert Vogelstein,et al.  The GLI gene is a member of the Kruppel family of zinc finger proteins , 1988, Nature.

[78]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[79]  S. Shankar,et al.  Resveratrol Inhibits Pancreatic Cancer Stem Cell Characteristics in Human and KrasG12D Transgenic Mice by Inhibiting Pluripotency Maintaining Factors and Epithelial-Mesenchymal Transition , 2011, PloS one.

[80]  L. Soane,et al.  A New View of the Lethal Apoptotic Pore , 2012, PLoS biology.

[81]  W. Peters,et al.  Quantification of induction of rat oesophageal, gastric and pancreatic glutathione and glutathione S-transferases by dietary anticarcinogens. , 1994, Carcinogenesis.

[82]  G. Sudhandiran,et al.  Ellagic acid prevents rat colon carcinogenesis induced by 1, 2 dimethyl hydrazine through inhibition of AKT-phosphoinositide-3 kinase pathway. , 2011, European journal of pharmacology.

[83]  D. Jenkins.  Hedgehog signalling: emerging evidence for non-canonical pathways. , 2009, Cellular signalling.

[84]  N. Jamieson,et al.  Tissue Biomarkers for Prognosis in Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-analysis , 2011, Clinical Cancer Research.

[85]  K. Pavelić,et al.  Metastasis: new perspectives on an old problem , 2011, Molecular Cancer.

[86]  S. Shankar,et al.  The dietary bioflavonoid quercetin synergizes with epigallocathechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelial-mesenchymal transition , 2010, Journal of molecular signaling.